Yes, Benadryl (diphenhydramine) is pharmacologically classified as a deliriant when taken at doses well above the recommended amount. At standard allergy doses, it works as an antihistamine. But at high doses, its secondary effects on the brain’s signaling system produce a specific type of hallucination and confusion that defines the deliriant drug class.
What Makes Benadryl a Deliriant
Deliriants are a subclass of hallucinogenic substances, but they produce a very different experience from psychedelics like LSD or psilocybin. The hallmark of a deliriant is true delirium: the person cannot distinguish hallucinations from reality, loses awareness of their surroundings, and often has no memory of the episode afterward. Diphenhydramine fits this category because of its anticholinergic activity, meaning it blocks a chemical messenger called acetylcholine in the brain.
Acetylcholine plays a central role in learning, memory, and maintaining a coherent sense of what’s real. When high doses of diphenhydramine flood the brain’s receptors and block this messenger, the result is confusion, disorientation, and hallucinations that feel indistinguishable from waking life. This is the defining feature that separates deliriants from other hallucinogens: people on psychedelics typically know they’re hallucinating, while people in anticholinergic delirium do not.
Why Normal Doses Don’t Cause This
At the standard dose of 25 to 50 milligrams, diphenhydramine primarily blocks histamine receptors, which is what relieves allergy symptoms and causes drowsiness. Its anticholinergic effects at this dose are mild, showing up as dry mouth, slight urine retention, or constipation. The deliriant effects only emerge when someone takes several times the recommended amount, overwhelming the brain’s acetylcholine system rather than just nudging it.
Peak blood levels occur about 2 to 3 hours after swallowing a dose, and normal effects last 4 to 6 hours. The drug’s half-life averages around 8.5 hours, meaning it takes roughly that long for the body to clear half of it. At toxic doses, the timeline stretches considerably because the body simply can’t process the drug fast enough.
What Anticholinergic Delirium Looks and Feels Like
People experiencing diphenhydramine-induced delirium commonly report seeing and talking to people who aren’t there, encountering shadow figures, or watching insects crawl across surfaces. Unlike the geometric patterns or color shifts associated with psychedelics, these hallucinations are mundane and realistic, which is part of what makes them so disorienting. The person genuinely believes they’re interacting with real people or objects.
The physical signs of anticholinergic toxicity are distinctive: dry, flushed skin, dilated pupils, rapid heart rate, elevated body temperature, inability to urinate, and extreme restlessness or agitation. Medical professionals sometimes summarize the syndrome as “blind as a bat, dry as a bone, red as a beet, mad as a hatter, hot as a hare.” These physical symptoms accompany the mental confusion and can become dangerous on their own.
Serious Health Risks at High Doses
The FDA issued a public warning in September 2020 after reports of teenagers and young adults ending up in emergency rooms, and in some cases dying, after taking large quantities of diphenhydramine as part of a social media trend called the “Benadryl Challenge.” The agency stated directly that high doses can cause serious heart rhythm disturbances, seizures, coma, or death.
Cardiac complications are the most immediately life-threatening risk. Diphenhydramine at toxic levels disrupts the electrical signals that keep the heart beating in rhythm, which can trigger fatal arrhythmias with little warning. Seizures are another major concern, and they can occur even in people with no history of seizure disorders. The margin between a dose that produces hallucinations and one that causes a medical emergency is narrow and unpredictable, varying significantly between individuals based on body weight, tolerance, and other medications.
Long-Term Effects on the Brain
Even at recommended doses, regular use of anticholinergic drugs like diphenhydramine raises concerns about cognitive health over time. Acetylcholine production naturally declines with age, so blocking it with medication compounds the problem. Research published through Harvard Health has linked cumulative anticholinergic use in older adults to increased dementia risk. Short-term memory problems, difficulty reasoning, and confusion are among the most common side effects even at normal doses, particularly in older people.
This is why second-generation antihistamines (like cetirizine or loratadine) are now preferred for regular allergy treatment. They don’t cross into the brain as readily and lack the anticholinergic punch that gives diphenhydramine both its sedating qualities and its deliriant potential.
Why Diphenhydramine Stands Apart
Not all antihistamines are deliriants. The deliriant classification applies specifically because diphenhydramine crosses the blood-brain barrier easily and blocks muscarinic acetylcholine receptors at higher doses. Second-generation antihistamines were specifically designed to avoid this. Other substances in the deliriant class include certain plants like jimsonweed and henbane, which contain naturally occurring anticholinergic compounds that work through the same receptor-blocking mechanism.
The fact that diphenhydramine is sold over the counter and marketed as a gentle allergy and sleep aid creates a misleading sense of safety. At its intended dose, it is safe for most adults. But its pharmacology at high doses places it squarely in the same drug category as some of the most disorienting and physically dangerous hallucinogens known.